Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nitric Oxide Supplementation as a Therapeutic Intervention in Argininosuccinic Aciduria

NCT02252770 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT02252770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02252770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nitric Oxide Supplementation as a Therapeutic Intervention in Argininosuccinic Aciduria
Lead sponsor
Baylor College of Medicine
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2014
Completion date
May 31, 2018
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

argininosuccinate lyase deficiency, argininosuccinic aciduria, urea cycle disorders